Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S. Faye Williamson"'
Autor:
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S. Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-5 (2023)
Abstract In the UK, the Medicines and Healthcare products Regulatory Agency consulted on proposals “to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medic
Externí odkaz:
https://doaj.org/article/b3bab057419146f7a2a0ab4aaefdc771
Publikováno v:
Diagnostic and Prognostic Research, Vol 7, Iss 1, Pp 1-24 (2023)
Abstract Background In a pandemic setting, it is critical to evaluate and deploy accurate diagnostic tests rapidly. This relies heavily on the sample size chosen to assess the test accuracy (e.g. sensitivity and specificity) during the diagnostic acc
Externí odkaz:
https://doaj.org/article/b2eb145834c94378b89b29bbbba999e2
Autor:
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S. Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/40c2eed3118c4c9da008c2e610d68b01
Autor:
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Philip Pallmann, Mark Pilling, David Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
In the United Kingdom, the Medicines and Healthcare products Regulatory Agency consulted on proposals “to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc5d509303991b84d47ca52b8c3ff2e7
https://doi.org/10.21203/rs.3.rs-2210654/v1
https://doi.org/10.21203/rs.3.rs-2210654/v1
Autor:
S. Faye Williamson, Michael J. Grayling, Adrian P. Mander, Nurulamin M. Noor, Joshua S. Savage, Christina Yap, James M.S. Wason
Objective\ud To investigate how subgroup analyses of published Randomised Controlled Trials (RCTs) are performed when subgroups are created from continuous variables.\ud \ud Study design and setting\ud We carried out a review of RCTs published in 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c430af00d594361282ae1d555072696c
https://orca.cardiff.ac.uk/id/eprint/151084/1/PIIS0895435622001688.pdf
https://orca.cardiff.ac.uk/id/eprint/151084/1/PIIS0895435622001688.pdf
Autor:
S. Faye Williamson, Sofia S. Villar
Publikováno v:
Biometrics
We propose a novel response‐adaptive randomization procedure for multi‐armed trials with continuous outcomes that are assumed to be normally distributed. Our proposed rule is non‐myopic, and oriented toward a patient benefit objective, yet main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b13ee5f6d7d333f066e11cd32c921c3
http://europepmc.org/articles/PMC7078926
http://europepmc.org/articles/PMC7078926
Autor:
Kevin J. Wilson, S. Faye Williamson, A. Joy Allen, Cameron J. Williams, Thomas P. Hellyer, B. Clare Lendrem
The development of a new diagnostic test ideally follows a sequence of stages which, amongst other aims, evaluate technical performance. This includes an analytical validity study, a diagnostic accuracy study and an interventional clinical utility st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0f9909833ba5779d3a7b4dab197a30d
Autor:
Peter K. Kimani, Martin Posch, Werner Brannath, Lisa V. Hampson, James Wason, Johannes Krisam, Thomas Jaki, S. Faye Williamson, Nigel Stallard, Sarah Zohar, Thomas Burnett, John Whitehead, Norbert Benda, Pavel Mozgunov, Franz Koenig, Gernot Wassmer, Tim Friede
Publikováno v:
Statistics in Biopharmaceutical Research
Statistics in Biopharmaceutical Research, 2020, 12 (4), pp.483-497. ⟨10.1080/19466315.2020.1790415⟩
article-version (VoR) Version of Record
Statistics in Biopharmaceutical Research, 2020, 12 (4), pp.483-497. ⟨10.1080/19466315.2020.1790415⟩
article-version (VoR) Version of Record
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9e91dcef704c907a1dfc0389c3ff5a
https://hal.archives-ouvertes.fr/hal-03122983
https://hal.archives-ouvertes.fr/hal-03122983